TY - JOUR
T1 - Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle Disease Virus
AU - Ryan, C
AU - Zaitsev, V
AU - Tindal, DJ
AU - Dyason, JC
AU - Thompson, RJ
AU - Alymova, I
AU - Portner, A
AU - von Itzstein, M
AU - Taylor, Garry Lindsay
PY - 2006/2
Y1 - 2006/2
N2 - Viruses of the Paramyxoviridae family are the leading cause of respiratory disease in children. The human parainfluenza viruses (hPIV) are members of the Paramyxovirinae subfamily, which also includes mumps virus, Newcastle disease virus (NDV), Sendai virus (SV) and simian type 5 virus (SV5). On the surface of these viruses is the glycoprotein hemagglutinin-neuraminidase (HN), which is responsible for cell attachment, promotion of fusion and release of progeny virions. This multifunctional nature of HN makes it an attractive target for the development of inhibitors as a treatment for childhood respiratory diseases. Here we report the crystal structure of NDV HN in complex with a derivative of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, Neu5Ac2en, that has a functional group designed to occupy a large conserved binding pocket around the active site. The purpose of this study was to examine the effect of a bulky hydrophobic group at the O4 position of Neu5Ac2en, given the hydrophobic nature of the binding pocket. This derivative, with a benzyl group added to the O4 position of Neu5Ac2en, has an IC50 of similar to 10 mu M in a neuraminidase assay against hPIV3 HN. The IC50 value of the parent compound, Neu5Ac2en, in the same assay is similar to 25 mu M. These results highlight the striking difference between the influenza neuraminidase and paramyxovirus HN active sites, and provide a platform for the development of improved HN inhibitors.
AB - Viruses of the Paramyxoviridae family are the leading cause of respiratory disease in children. The human parainfluenza viruses (hPIV) are members of the Paramyxovirinae subfamily, which also includes mumps virus, Newcastle disease virus (NDV), Sendai virus (SV) and simian type 5 virus (SV5). On the surface of these viruses is the glycoprotein hemagglutinin-neuraminidase (HN), which is responsible for cell attachment, promotion of fusion and release of progeny virions. This multifunctional nature of HN makes it an attractive target for the development of inhibitors as a treatment for childhood respiratory diseases. Here we report the crystal structure of NDV HN in complex with a derivative of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, Neu5Ac2en, that has a functional group designed to occupy a large conserved binding pocket around the active site. The purpose of this study was to examine the effect of a bulky hydrophobic group at the O4 position of Neu5Ac2en, given the hydrophobic nature of the binding pocket. This derivative, with a benzyl group added to the O4 position of Neu5Ac2en, has an IC50 of similar to 10 mu M in a neuraminidase assay against hPIV3 HN. The IC50 value of the parent compound, Neu5Ac2en, in the same assay is similar to 25 mu M. These results highlight the striking difference between the influenza neuraminidase and paramyxovirus HN active sites, and provide a platform for the development of improved HN inhibitors.
KW - neuraminidase
KW - sialidase
KW - hemagglutinin-neuraminidase
KW - structure-based drug design
KW - Newcastle disease virus
KW - parainfluenza
KW - ACID BINDING-SITE
KW - INFLUENZA-VIRUS
KW - PROTEIN
KW - FUSION
KW - CRYSTALLOGRAPHY
KW - RECEPTOR
UR - http://www.scopus.com/inward/record.url?scp=33645453800&partnerID=8YFLogxK
U2 - 10.1007/s10719-006-5446-8
DO - 10.1007/s10719-006-5446-8
M3 - Article
SN - 0282-0080
VL - 23
SP - 135
EP - 141
JO - Glycoconjugate Journal
JF - Glycoconjugate Journal
ER -